Taysha Gene Therapies, Inc. · NASDAQ:TSHA

Morgan Stanley reported a 8.60% stake in Taysha Gene Therapies, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 5, 2025

Morgan Stanley reported a 8.60% stake in Taysha Gene Therapies, Inc., 17,629,264 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G).

Stake
8.60%
Shares
17,629,264
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Morgan Stanley8.60%17,629,264
Morgan Stanley Capital Services LLC7.00%14,375,830

Source

View original at SEC

Related